Joseph Mahady has been appointed president, global business, Wyeth Pharmaceuticals and senior vice president, Wyeth. Mr. Mahady will continue to report to Bernard Poussot, president, chief operating officer and vice chairman of Wyeth.

In his new role, Mr. Mahady assumes operational responsibility for the company's global pharmaceutical business, including Europe/Middle East/Africa, Asia/Pacific, and Wyeth Nutrition, in addition to his current responsibilities for the Americas and the four strategic global business units: Pharmaceuticals, BioPharma, Vaccines and Women's Health Care.

Mr. Mahady joined the company in 1979 as a pharmacist in regulatory affairs. He has held several key commercial positions. He was appointed president, U.S. in 1995 and has since assumed responsibilities for the remainder of the Americas and for the global business units.

Also, Geno Germano has been appointed president, U.S. and general manager, Wyeth Pharmaceuticals. In this new role, Mr. Germano will continue to report to Mr. Mahady.

Mr. Germano joined the company in 1984 as a sales representative and has held positions of increasing responsibility in sales, marketing, business development and general management, including managing director, Wyeth Australia and New Zealand; executive vice president and general manager for Wyeth Global Vaccines; and most recently, executive vice president, Pharmaceutical Business Unit.

News from our sister sites